Home health and hospice company Amedisys, Inc. (NASDAQ:AMED) reported a net income of $7.2 million for the fourth quarter ended Dec. 31, 2012 on an adjusted basis, a 50.5% decrease from the previous year’s fourth quarter proceeds of $14.5 million. For all of 2012, earnings attributable to Amedisys were down nearly 51% to $32.8 million. […]
Amedisys Inc.
An article posted last week by the Wall Street Journal reported that the steps to reducing hospital readmission rates is “without an easy fix.” Detailing recent studies linking readmission rates to poor post-care coordination, the article caught the attention of Amedisys’ Chief Medical Officer Michael Fleming, MD, FAAFP. Because the nation’s healthcare needs are changing, Fleming […]
The 2012 HomeCare Elite list was announced last week, ranking the top 100 and top 500 home health agencies in the nation. Gentiva Health Services, Amedisys Home Health, and Maxim Healthcare Services topped the list this year. Using publicly available data from Home Health Compare and the Centers for Medicare & Medicaid Services (CMS), OCS […]
Amedisys, Inc. (NASDAQ: AMED), provider of home health and hospice care, suffered a 65.8% decline in earnings per share (EPS), during the second quarter of 2012 due to large cuts in Medicare reimbursements and the implementation of Medicare’s face-to-face law, according the company’s second quarter financial report. Despite decline to an EPS of 27 cents, the company […]
Subscribe
Receive industry updates and breaking news from HHCN